Menopause with a history of endometriosis

A history of endometriosis changes some important details about how menopause is managed — most notably, the type of hormone therapy that's actually safest for you. This isn't a minor technicality: getting it wrong can mean an unnecessary risk of reactivating the condition.

The most important thing to know: estrogen-only therapy isn't automatically safe after hysterectomy

For most women, a hysterectomy (uterus removed) means estrogen-only hormone therapy is an option, because there's no uterus lining to protect from unopposed estrogen's endometrial cancer risk. This general rule doesn't straightforwardly apply if you have a history of endometriosis.

A 2025 clinical guide from the European Menopause and Andropause Society (EMAS) states that estrogen-only MHT should be avoided, even for women who have had a hysterectomy, if they have a history of endometriosis. The reasoning: endometriosis tissue can remain in the pelvis even after the uterus is removed, and estrogen alone can reactivate it or, rarely, drive malignant transformation. Instead, the guide recommends continuous combined MHT (estrogen plus a progestogen) as the safer regimen for both hysterectomized and non-hysterectomized women with this history, since the added progestogen may reduce the risk of recurrence and malignant transformation of any residual tissue.

What else the guide covers

• Endometriosis itself can bring menopause earlier. The guide notes that endometriosis, or its treatment, may lead to premature or early menopause — worth knowing if you're younger than the typical menopause age and have this history.
• Related health risks worth monitoring. Endometriosis is associated with an increased risk of cardiovascular disease, ovarian, breast, and thyroid cancers, and osteoporosis — reasons to stay engaged with regular care rather than reasons to panic.
• Surgery is the preferred option for symptomatic postmenopausal endometriosis. If pain or other symptoms persist or return after menopause, the guide recommends surgery as the preferred management, since it reduces pain, confirms an accurate diagnosis, and lowers malignancy risk.
• If symptoms return while on hormone therapy, the guide outlines several options: adjusting the regimen, stopping hormone therapy, or switching to non-hormonal strategies.

If hormone therapy isn't right for you

For vasomotor symptoms without hormone therapy, the guide points to neurokinin-3 receptor antagonists (the class that includes fezolinetant) as an option, alongside antiresorptive or anabolic therapies plus calcium and vitamin D specifically for bone protection.

One notable caution: the guide explicitly advises against herbal preparations, because their efficacy is uncertain and some contain estrogenic compounds — which matters more for you than for the general population, given the estrogen-sensitivity of residual endometriosis tissue. Check any specific supplement against our does it work? evidence directory before trying it, since several marketed menopause supplements are soy- or botanical-estrogen sources.

Logging any symptoms that return — pain, bleeding, or vasomotor symptoms — in our symptom tracker can help your clinician judge whether it's a recurrence worth investigating.

Questions to take to your clinician

Build a printable version in our treatment conversation builder: